Skip to main content
. 2017 May 28;2017:8178643. doi: 10.1155/2017/8178643

Figure 5.

Figure 5

(a) Wound-healing assay demonstrated that MSCs and MSCs-EP2 migration was markedly reduced in the presence of ERK1/2 inhibitor PD98059. (b) Transwell assay revealed that the number of ERK1/2 inhibitor PD98059 treated MSCs and MSCs-EP2 traversing the membrane was significantly less than the untreated control when incubated with PGE2, P < 0.05.